Update shared on 18 Dec 2025
Analysts have slightly lifted their price target on CK Hutchison Holdings, citing a modest improvement in long term valuation assumptions, underpinned by stable growth expectations and profitability metrics.
What's in the News
- CK Hutchison Holdings is exploring a potential listing of its health and beauty arm, A.S. Watson, with early-stage discussions under way with financial advisers about timing and structure (Key Developments).
- A Hong Kong listing of A.S. Watson could raise around USD 2 billion or more, reflecting the scale of the business and its contribution to the group’s valuation (Key Developments).
- The company is also considering a possible dual listing of A.S. Watson in Hong Kong and the UK, with a transaction potentially targeted for the first half of next year (Key Developments).
- A.S. Watson operates more than 17,000 stores across 31 markets, including Superdrug in the UK, Rossmann pharmacies in Germany, and Watsons stores across Asia, underscoring its global retail footprint (Key Developments).
- Singapore state investment firm Temasek holds about 25 percent of A.S. Watson, and any listing decisions would likely involve coordination with the minority shareholder (Key Developments).
Valuation Changes
- Fair Value Estimate unchanged at HK$62.01 per share, reflecting stable long term assumptions.
- Discount Rate risen slightly from 10.56 percent to 10.72 percent, implying a marginally higher required return.
- Revenue Growth effectively unchanged at about 10.92 percent, indicating consistent top line expectations.
- Net Profit Margin broadly stable at around 9.23 percent, signaling no material shift in profitability assumptions.
- Future P/E nudged higher from 8.97x to 9.01x, pointing to a modestly stronger relative valuation multiple.
Have other thoughts on CK Hutchison Holdings?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
